Projects per year
Organization profile
Organization profile
The Hormel Institute’s vision is specific: Improve the health of the world The Hormel Institute remains focused on the vision it has had since its beginning in 1942…to help humanity by improving health through scientific research. In sixty-five years of medical research, The Hormel Institute has made significant discoveries that have advanced the health potential for people globally. The Hormel Institute is a world-recognized leader in the scientific field showing that dietary factors prevent and control cancer development. The institute is accelerating cancer research discoveries to achieve its mission: Improve your health and well-being.
Fingerprint Dive into the research topics where Hormel Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Neoplasms
Medicine & Life Sciences
Transcription Factor AP-1
Medicine & Life Sciences
Phosphorylation
Medicine & Life Sciences
Phosphotransferases
Medicine & Life Sciences
Carcinogenesis
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Growth
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Amer Alam
- Office of the Vice President for Research, Hormel Institute - Assistant Professor
Person: Faculty
Sk. Kayum Alam
- Office of the Vice President for Research, Hormel Institute - Post-Doctoral Associate
Person: Professional-in-Training
Georgiy Aslanidi
- Office of the Vice President for Research, Hormel Institute - Associate Professor
Person: Faculty
Projects 1992 2023
A novel UV signature for assessing skin UV damage and cancer risk
1/15/19 → 1/14/21
Project: Research project
Skin
Neoplasms
Discovery of a novel beta-catenin inhibitor that shows potent therapeutic effects against colon cancer
UNIVERSITY OF MINNESOTA FOUNDATION
1/1/19 → 12/31/19
Project: Research project
beta Catenin
Therapeutic Uses
Colonic Neoplasms
Targeting eIF4A1-dependent HK2 translation axis for prevention of castration-resistant prostate cancer
Deng, Y., Aihara, H., Bhat, M. S., Murugan, P. & Zhang, L.
NIH NATIONAL CANCER INSTITUTE (NCI)
12/1/18 → 11/30/23
Project: Research project
Castration
Prostatic Neoplasms
Research Output 1977 2019
3,3’-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2
Tian, X., Liu, K. D., Zu, X., Ma, F., Li, Z., Lee, M. H., Chen, H., Li, Y., Zhao, Y., Liu, F., Oi, N., Bode, A. M., Dong, Z. & Kim, D. J., Apr 28 2019, In : Cancer Letters. 448, p. 20-30 11 p.Research output: Contribution to journal › Article
Heterografts
Colon
Growth
Neoplasms
Colonic Neoplasms
2
Citations
(Scopus)
AKt as a therapeutic target for cancer
Song, M., Bode, A. M., Dong, Z. & Lee, M. H., Jan 1 2019, In : Cancer Research. 79, 6, p. 1019-1031 13 p.Research output: Contribution to journal › Review article
Phosphatidylinositol 3-Kinases
Neoplasms
Phosphotransferases
Glycogen Synthase Kinases
Thymoma
Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
Zhao, Z., Jin, G., Yao, K., Liu, K., Liu, F., Chen, H., Wang, K., Gorja, D. R., Kanamata Reddy, S. R., Bode, A. M., Guo, Z. & Dong, Z., Jun 1 2019, In : Molecular Carcinogenesis. 58, 6, p. 1056-1067 12 p.Research output: Contribution to journal › Article
Aurora Kinase B
Osteosarcoma
Growth
Heterografts
Tissue Array Analysis